Morgan Stanley’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Sell |
|
|||||
|
2025
Q1 | $466K | Sell |
|
|||||
|
2024
Q4 | $777K | Sell |
|
|||||
|
2024
Q3 | $2.38M | Buy |
|
|||||
|
2024
Q2 | $654K | Sell |
|
|||||
|
2024
Q1 | $1.22M | Sell |
|
|||||
|
2023
Q4 | $2.12M | Buy |
|
|||||
|
2023
Q3 | $375K | Sell |
|
|||||
|
2023
Q2 | $1.12M | Buy |
|
|||||
|
2023
Q1 | $580K | Buy |
|
|||||
|
2022
Q4 | $760K | Sell |
|
|||||
|
2022
Q3 | $3.04M | Buy |
|
|||||
|
2022
Q2 | $1.42M | Sell |
|
|||||
|
2022
Q1 | $1.81M | Sell |
|
|||||
|
2021
Q4 | $7.75M | Buy |
|
|||||
|
2021
Q3 | $7.98M | Sell |
|
|||||
|
2021
Q2 | $26.7M | Buy |
|